Monday, February 26, 2024
Reversing osteoarthritis. Introducing an unprecedented category innovation in nanotechnology to fully restore the joint function in osteoarthritic patients, with impeccable results paving the way to completely change the landscape of osteoarthritis treatments.
CEO/Top Company Official
Lead Product in Development
Xyletra, an injectable nanotechnology for the treatment of osteoarthritis.
Development Phase of Primary Product
Number Of Unlicensed Products